000			01913 a2200565 4500
005			20250515230320.0
264		0	_c20101012
008			201010s 0 0 eng d
022			_a0008-543X
024	7		_a10.1002/cncr.25277 _2doi
040			_aNLM _beng _cNLM
100	1		_aTsimberidou, Apostolia M
245	0	0	_aA phase 1 study of hepatic arterial infusion of oxaliplatin in combination with systemic 5-fluorouracil, leucovorin, and bevacizumab in patients with advanced solid tumors metastatic to the liver. _h[electronic resource]
260			_bCancer _cSep 2010
300			_a4086-94 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase I; Journal Article
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntibodies, Monoclonal _xadministration & dosage
650	0	4	_aAntibodies, Monoclonal, Humanized
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects
650	0	4	_aBevacizumab
650	0	4	_aChild
650	0	4	_aDisease-Free Survival
650	0	4	_aFemale
650	0	4	_aFluorouracil _xadministration & dosage
650	0	4	_aHumans
650	0	4	_aLeucovorin _xadministration & dosage
650	0	4	_aLiver Neoplasms _xdrug therapy
650	0	4	_aMale
650	0	4	_aMaximum Tolerated Dose
650	0	4	_aMiddle Aged
650	0	4	_aOrganoplatinum Compounds _xadministration & dosage
650	0	4	_aOxaliplatin
650	0	4	_aYoung Adult
700	1		_aFu, Siqing
700	1		_aNg, Chaan
700	1		_aLim, Jo Ann
700	1		_aWen, Sijin
700	1		_aHong, David
700	1		_aWheler, Jennifer
700	1		_aBedikian, Agop Y
700	1		_aEng, Cathy
700	1		_aWallace, Michael
700	1		_aCamacho, Luis H
700	1		_aKurzrock, Razelle
773	0		_tCancer _gvol. 116 _gno. 17 _gp. 4086-94
856	4	0	_uhttps://doi.org/10.1002/cncr.25277 _zAvailable from publisher's website
999			_c19912861 _d19912861